165 related articles for article (PubMed ID: 2551303)
1. Interaction of azithromycin and human phagocytic cells. Uptake of the antibiotic and the effect on the survival of ingested bacteria in phagocytes.
Wildfeuer A; Laufen H; Müller-Wening D; Haferkamp O
Arzneimittelforschung; 1989 Jul; 39(7):755-8. PubMed ID: 2551303
[TBL] [Abstract][Full Text] [Related]
2. The effect of antibiotics on the intracellular survival of bacteria in human phagocytic cells.
Wildfeuer A; Laufen H; Müller-Wening D; Galle J; Haferkamp O
Arzneimittelforschung; 1987 Dec; 37(12):1367-70. PubMed ID: 3502387
[TBL] [Abstract][Full Text] [Related]
3. Uptake and subcellular distribution of azithromycin in human phagocytic cells. Demonstration of the antibiotic in neutrophil polymorphonuclear leucocytes and monocytes by autoradiography and electron microscopy.
Wildfeuer A; Reisert I; Laufen H
Arzneimittelforschung; 1993 Apr; 43(4):484-6. PubMed ID: 8388213
[TBL] [Abstract][Full Text] [Related]
4. Interaction of fluconazole and human phagocytic cells. Uptake of the antifungal agent and its effects on the survival of ingested fungi in phagocytes.
Wildfeuer A; Laufen H; Haferkamp O
Arzneimittelforschung; 1990 Sep; 40(9):1044-7. PubMed ID: 2080941
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of azithromycin uptake in human polymorphonuclear leucocytes.
Laufen H; Wildfeuer A; Lach P
Arzneimittelforschung; 1990 Jun; 40(6):686-9. PubMed ID: 2168704
[TBL] [Abstract][Full Text] [Related]
6. Distribution of orally administered azithromycin in various blood compartments.
Wildfeuer A; Laufen H; Zimmermann T
Int J Clin Pharmacol Ther; 1994 Jul; 32(7):356-60. PubMed ID: 7952797
[TBL] [Abstract][Full Text] [Related]
7. Phagocyte uptake and transport of azithromycin.
McDonald PJ; Pruul H
Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):828-33. PubMed ID: 1662626
[TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine enhances in vitro the intracellular killing of Staphylococcus aureus by human alveolar macrophages and blood polymorphonuclear leukocytes and partially protects phagocytes from self-killing.
Oddera S; Silvestri M; Sacco O; Eftimiadi C; Rossi GA
J Lab Clin Med; 1994 Aug; 124(2):293-301. PubMed ID: 8051494
[TBL] [Abstract][Full Text] [Related]
9. The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment.
Dorfman MS; Wagner RS; Jamison T; Bell B; Stroman DW
Adv Ther; 2008 Mar; 25(3):208-17. PubMed ID: 18369536
[TBL] [Abstract][Full Text] [Related]
10. Influence of azithromycin and other macrolides on the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes of healthy donors and a patient with Chédiak-Higashi syndrome.
Paulsen P; Simon C; Peters O; Hedderich J; Heim P
Chemotherapy; 1992; 38(3):185-90. PubMed ID: 1324831
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of 50S ribosomal subunit assembly in Haemophilus influenzae cells by azithromycin and erythromycin.
Champney WS; Miller M
Curr Microbiol; 2002 Jun; 44(6):418-24. PubMed ID: 12000992
[TBL] [Abstract][Full Text] [Related]
12. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
Hansen CR; Pressler T; Hoiby N; Johansen HK
J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of flurithromycin, a novel macrolide antibiotic.
Gialdroni Grassi G; Alesina R; Bersani C; Ferrara A; Fietta A; Peona V
Chemioterapia; 1986 Jun; 5(3):177-84. PubMed ID: 3487389
[TBL] [Abstract][Full Text] [Related]
14. [Intracellular effects of josamycin].
Wildfeuer A; Laufen H; Galle J; Pfänder K
Arzneimittelforschung; 1986; 36(1):127-31. PubMed ID: 3954814
[TBL] [Abstract][Full Text] [Related]
15. Study of interaction between the polyoxidonium immunomodulator and the human immune system cells.
Dyakonova VA; Dambaeva SV; Pinegin BV; Khaitov RM
Int Immunopharmacol; 2004 Dec; 4(13):1615-23. PubMed ID: 15454114
[TBL] [Abstract][Full Text] [Related]
16. Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin. Collaborative Antimicrobial Susceptibility Testing Group.
Barry AL; Thornsberry C; Gavan TL
Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):544-9. PubMed ID: 2548865
[TBL] [Abstract][Full Text] [Related]
17. The effect of ofloxacin on the intracellular growth of Legionella pneumophila in guinea pig alveolar phagocytes.
Fitzgeorge RB; Featherstone AS; Baskerville A
J Antimicrob Chemother; 1988 Sep; 22 Suppl C():53-7. PubMed ID: 3182462
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of macrolides on human phagocytic functions.
Fietta A; Bersani C; Santagada T; Bertoletti R; Gialdroni Grassi G
Chemioterapia; 1987 Feb; 6(1):52-6. PubMed ID: 3829136
[TBL] [Abstract][Full Text] [Related]
19. Effect of azithromycin, roxithromycin and erythromycin on human polymorphonuclear leukocyte function against Staphylococcus aureus.
Pascual A; López-López G; Aragón J; Perea EJ
Chemotherapy; 1990; 36(6):422-7. PubMed ID: 1963394
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of azithromycin against clinical isolates of Legionella species.
Edelstein PH; Edelstein MA
Antimicrob Agents Chemother; 1991 Jan; 35(1):180-1. PubMed ID: 1849708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
